Dr. Lal Path Labs Ltd. — Updates, 30-04-2026: General Updates

Company reports robust FY26 consolidated revenue of ₹2,762.9 Cr and profit of ₹509.8 Cr. A final dividend of ₹4/share was declared, bringing the yearly total to ₹20.5/share. The company acquired Shahbazkers Diagnostic for up to ₹20 Cr to expand its Mumbai presence and will establish a Dubai subsidiary for global growth.